| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:522575019:2064 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:522575019:2064?format=raw |
LEADER: 02064cam a2200433 4500
001 3964576
005 20221027011107.0
008 920330s1970 sz a b 101 0 eng
010 $a 79543786
015 $aSw70-A-5402
035 $a(OCoLC)501423192
035 $a(OCoLC)ocn501423192
035 $a(CStRLIN)NYCM92-B2403
035 $9AGA1232HS
035 $a(NNC)3964576
035 $a3964576
040 $dNNC-M
050 00 $aRM260$b.A55 vol. 16
082 0 $a616.9/95/061
245 00 $aExperimental and clinical evaluation of the tuberculostatics :$bcapreomycin, Isoxyl, Myambutol, Rifampicin ; International colloquium Borstel held at Borstel Research Institute May 1968 /$cEdited by E. Freerksen, E.-H. Orlowski, J. H. Thumim.
260 $aBasel ;$aNew York :$bS. Karger,$c1970.
300 $ax, 537 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aAntibiotica et chemotherapia ;$vv. 16
500 $aHeld at Borstel Research Institute.
504 $aIncludes bibliographical references and index.
650 0 $aAntitubercular agents$vCongresses.
650 0 $aTuberculosis$xChemotherapy$vCongresses.
650 2 $aAntitubercular Agents$xpharmacology.$0https://id.nlm.nih.gov/mesh/D000995Q000494
650 2 $aCapreomycin$xpharmacology.$0https://id.nlm.nih.gov/mesh/D002207Q000494
650 2 $aRifampin$xpharmacology.$0https://id.nlm.nih.gov/mesh/D012293Q000494
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aFreerksen, Enno,$eeditor.$4http://id.loc.gov/vocabulary/relators/edt$0http://id.loc.gov/authorities/names/no2009000374
700 1 $aOrlowski, E.-H.,$eeditor.$4http://id.loc.gov/vocabulary/relators/edt
700 1 $aThumim, Jürgen H.,$eeditor.$4http://id.loc.gov/vocabulary/relators/edt
710 2 $aTuberkulose-Forschungsinstitut Borstel.$0http://id.loc.gov/authorities/names/n2018187141
830 0 $aAntibiotica et chemotherapia ;$vv. 16.$0http://id.loc.gov/authorities/names/n86742237
852 80 $boff,hsr$hSerial$iA